Back to Search
Start Over
Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone.
- Source :
-
ACG case reports journal [ACG Case Rep J] 2023 Jan 20; Vol. 10 (1), pp. e00955. Date of Electronic Publication: 2023 Jan 20 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Simultaneous occurrence of multiple sclerosis (MS) and ulcerative colitis (UC) is seldom encountered by clinicians and poses unique challenges. The sphingosine-1-phosphate receptor modulator ozanimod has been recently approved for UC. Ozanimod can be used in such scenarios where it can treat both conditions, reducing the need for multiple targeted therapies. We report the first case of successfully treated multiple sclerosis and UC with ozanimod.<br /> (© 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.)
Details
- Language :
- English
- ISSN :
- 2326-3253
- Volume :
- 10
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- ACG case reports journal
- Publication Type :
- Report
- Accession number :
- 36699181
- Full Text :
- https://doi.org/10.14309/crj.0000000000000955